Review: progesterone or progestogens lead to a marginal reduction in premenstrual syndrome symptoms.

The author conducted an analysis of randomized, double blind, placebo-controlled studies of progesterone or progestins in women diagnosed with PMS.  Oral micronized progesterone and the progestogens MPA, norethisterone and dydrogesterone, all showed a marginal benefit over placebo in symptom reduction.

Author: Yonkers K.

Publication Year: 2002

Citation: Evid Based Ment Health 2002;5(2):56.

http://www.ncbi.nlm.nih.gov/pubmed/12026905